Richeng Jiang
Impact in
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 30
- Lung Cancer Research Studies 15
- Cancer Immunotherapy and Biomarkers 10
- Inflammatory Biomarkers in Disease Prognosis 5
- Peptidase Inhibition and Analysis 5
-
- Lung Cancer Treatments and Mutations 16
- Ferroptosis and cancer prognosis 7
- Lung Cancer Diagnosis and Treatment 7
- Co-authors
- Yun Qiu (4 shared papers)Feng Sun (4 shared papers)Douglas E. Linn (3 shared papers)Zhiyong Guo (3 shared papers)Hegang Chen (3 shared papers)Xi Yang (3 shared papers)Xiangtian Kong (2 shared papers)Jonathan Melamed (2 shared papers)
- Journals
- Journal of Cancer (3 papers)Journal of Thoracic Oncology (2 papers)Frontiers in Immunology (2 papers)Cancer Letters (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Richeng Jiang
44 papers receiving 1.8k citations
Richeng Jiang's Hit Papers
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 390
- Oncology 600
- Endocrinology, Diabetes and Metabolism 246
- Molecular Biology 952
Countries citing papers authored by Richeng Jiang
This map shows the geographic impact of Richeng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richeng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richeng Jiang more than expected).
Fields of papers citing papers by Richeng Jiang
This network shows the impact of papers produced by Richeng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richeng Jiang. The network helps show where Richeng Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Richeng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth Hit paper breakdown → | 2009 | 698 |
| 2 | 2008 | 206 | |
| 3 | 2009 | 183 | |
| 4 | 2010 | 83 | |
| 5 | 2013 | 72 | |
| 6 | 2011 | 68 | |
| 7 | 2014 | 45 | |
| 8 | 2018 | 41 | |
| 9 | 2017 | 40 | |
| 10 | 2021 | 36 | |
| 11 | 2009 | 34 | |
| 12 | 2021 | 33 | |
| 13 | 2016 | 27 | |
| 14 | 2017 | 23 | |
| 15 | 2018 | 23 | |
| 16 | 2016 | 22 | |
| 17 | 2022 | 21 | |
| 18 | 2019 | 19 | |
| 19 | 2011 | 19 | |
| 20 | 2019 | 17 |
About Richeng Jiang
Richeng Jiang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (15 papers), Cancer Immunotherapy and Biomarkers (10 papers), Ferroptosis and cancer prognosis (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (390 citations), Oncology (600 citations), Endocrinology, Diabetes and Metabolism (246 citations) and Molecular Biology (952 citations). Richeng Jiang has collaborated with scholars based in China, United States and France. Frequent co-authors include Yun Qiu, Feng Sun, Douglas E. Linn, Zhiyong Guo, Hegang Chen, Xi Yang, Xiangtian Kong, Jonathan Melamed, Hege Chen and Hsing-Jien Kung. Their work appears in journals such as Journal of Cancer, Journal of Thoracic Oncology, Frontiers in Immunology, Cancer Letters and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.